We aimed to explore the effects of miR-29b-3p on malignant biological behaviors of AML and the involvement of the NF-κB and JAK/STAT signaling pathways by targeting HuR, in the hope of providing a novel molecular target for the treatment of AML. This evidence concerns the gene ELAVL1 and acute myeloid leukemia.